{"success":true,"type":"rich","version":"1.0","cache_age":86400,"width":440,"height":500,"provider_name":"RiffReporter","provider_url":"https:\/\/www.riffreporter.de","safety":"nonadult","asset_type":"article","url":"https:\/\/www.riffreporter.de\/de\/wissen\/car-t-zellen-immuntherapie-organfibrose-herz-leber-heilung","category":"Wissen","author_name":"Ulrike Gebhardt","author_url":"https:\/\/www.riffreporter.de\/de\/autorinnen-und-autoren\/ulrike-gebhardt","title":"CAR-T-Zellen: Revolution\u00e4re Therapie gegen Organvernarbung","summary":"Forschende entwickeln neue Generation von CAR-T-Zellen zur Behandlung von Herz- und Leberfibrosen. Erste Studienergebnisse zeigen vielversprechende Resultate.","publication_date":"28.02.2026","thumbnail_url":"https:\/\/riff.media\/images\/car-t-zelle-fibrose.jpg?w=440&h=247&fit=crop-50-50&s=210243fffb097491751c0c068f223a38","thumbnail_width":440,"thumbnail_height":247,"thumbnail_credit":null,"thumbnail_credit_url":null,"thumbnail_credit_note":null,"html":"